Grant: Project Grant
Research Institute of the McGill University Health Centre
$589,052.00
Enabling and Engaging patients to DECIDE indefinite versus short-term anticoagulation for VTE (DECIDE-VTE): A Stepped-Wedge Cluster Randomized Trial
FY 2025-26
Summary
After patients get a blood clot in their veins (deep vein thrombosis or pulmonary embolism), they take blood thinners for at least three months. After that, there is a tight trade-off in risk and benefit from continuing blood thinners indefinitely. Continuing blood thinners lowers the chance of another clot but increases the bleeding risk. We are testing a new decision aid tool that helps patients and doctors weigh the pros and cons together. This study will see if the tool improves patients' understanding and comfort with their decision.
Department
Program
Project Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
534828
Name
Rodger Marc A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Clinical Investigation - D: Cardiovascular Systems
Projecttitle
Enabling and Engaging patients to DECIDE indefinite versus short-term anticoagulation for VTE (DECIDE-VTE): A Stepped-Wedge Cluster Randomized Trial
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$589,052
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Anticoagulation Decision-Making; Extended Anticoagulation Therapy; Knowledge Translation; Patient Decision Aid; Patient-Centred Outcomes; Risk-Benefit Communication; Shared Decision-Making; Stepped-Wedge Cluster Randomized Trial; Venous Thromboembolism
Abstract
After patients get a blood clot in their veins (deep vein thrombosis or pulmonary embolism), they take blood thinners for at least three months. After that, there is a tight trade-off in risk and benefit from continuing blood thinners indefinitely. Continuing blood thinners lowers the chance of another clot but increases the bleeding risk. We are testing a new decision aid tool that helps patients and doctors weigh the pros and cons together. This study will see if the tool improves patients' understanding and comfort with their decision.
Competitiondate
202509
Approvedterm2
4 yrs 0 mth
Pinamesdelim
Rodger, Marc A
Approvedterm
4 ans 0 mois
Cihrcontribution2
~ $589,052~ $0~
